12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Deals

Becton Dickinson, Carmel Pharma AB deal

Becton Dickinson will acquire Carmel for an undisclosed cash sum. Carmel manufactures the PhaSeal System, a closed-system drug transfer...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >